Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 5 mg/ml - solution, irrigation - excipient ingredients: cetrimide; glacial acetic acid; water for injections; methylene blue - chlorhexidine acetate (0.5 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 1 mg/ml - solution, irrigation - excipient ingredients: water for injections; glacial acetic acid; methylene blue - chlorhexidine acetate (0.1 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 0.5 mg/ml - solution, irrigation - excipient ingredients: glacial acetic acid; methylene blue; water for injections - chlorhexidine acetate (0.5 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 0.15 mg/ml; cetrimide, quantity: 1.5 mg/ml - solution, irrigation - excipient ingredients: water for injections; glacial acetic acid; tartrazine - chlorhexidine acetate (0.015 %) with cetrimide (0.15 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 400 mg/l; calcium chloride dihydrate, quantity: 270 mg/l - injection, solution - excipient ingredients: water for injections - compound sodium lactate solution and 5% glucose is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are compatible with the solutions.

Μάλτα - Αγγλικά - Malta Medicines Authority

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - anti, d immunoglobulin, human - solution for injection - anti-d immunoglobulin, human 625 iu/ml - immune sera and immunoglobulins

Μάλτα - Αγγλικά - Malta Medicines Authority

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - anti, d immunoglobulin, human - solution for injection - anti-d immunoglobulin, human 625 iu/ml - immune sera and immunoglobulins

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - midazolam, quantity: 5 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. iv for sedation in intensive care units; intermittent administration or continuous infusion. im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - midazolam, quantity: 50 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. iv for sedation in intensive care units; intermittent administration or continuous infusion. im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - fulvestrant, quantity: 250 mg - injection, solution - excipient ingredients: benzyl alcohol; castor oil; benzyl benzoate; ethanol - fulvestrant accord is indicated for the treatment of postmenopausal women with: ? hormone-receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, locally advanced or metastatic breast cancer who have not been previously treated with endocrine therapy. ? hr positive, locally advanced or metastatic breast cancer who have progressive disease following prior endocrine (anti-oestrogen or aromatase inhibitor) therapy.